- Home
- GMED vs BRKR Comparison
GMED vs BRKR Comparison
Compare GMED & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMED
- BRKR
- Stock Information
- Founded
- GMED 2003
- BRKR 1991
- Country
- GMED United States
- BRKR United States
- Employees
- GMED N/A
- BRKR N/A
- Industry
- GMED Medical/Dental Instruments
- BRKR Biotechnology: Laboratory Analytical Instruments
- Sector
- GMED Health Care
- BRKR Industrials
- Exchange
- GMED Nasdaq
- BRKR Nasdaq
- Market Cap
- GMED 9.7B
- BRKR 9.9B
- IPO Year
- GMED 2012
- BRKR 2000
- Fundamental
- Price
- GMED $69.26
- BRKR $63.99
- Analyst Decision
- GMED Buy
- BRKR Buy
- Analyst Count
- GMED 12
- BRKR 10
- Target Price
- GMED $77.36
- BRKR $80.11
- AVG Volume (30 Days)
- GMED 628.6K
- BRKR 886.3K
- Earning Date
- GMED 11-05-2024
- BRKR 10-31-2024
- Dividend Yield
- GMED N/A
- BRKR 0.32%
- EPS Growth
- GMED N/A
- BRKR 10.49
- EPS
- GMED 0.30
- BRKR 2.39
- Revenue
- GMED $2,236,530,000.00
- BRKR $3,119,700,000.00
- Revenue This Year
- GMED $61.37
- BRKR $17.05
- Revenue Next Year
- GMED $7.07
- BRKR $9.28
- P/E Ratio
- GMED $227.06
- BRKR $26.75
- Revenue Growth
- GMED 103.89
- BRKR 14.93
- 52 Week Low
- GMED $43.39
- BRKR $53.79
- 52 Week High
- GMED $74.21
- BRKR $94.86
- Technical
- Relative Strength Index (RSI)
- GMED 43.89
- BRKR 48.50
- Support Level
- GMED $69.25
- BRKR $63.57
- Resistance Level
- GMED $71.29
- BRKR $66.13
- Average True Range (ATR)
- GMED 1.38
- BRKR 2.03
- MACD
- GMED -0.26
- BRKR -0.14
- Stochastic Oscillator
- GMED 29.37
- BRKR 31.65
About GMED Globus Medical Inc.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.